Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline weighs an IPO for the HIV-focused ViiV as it sharpens the budget axe
GlaxoSmithKline weighs an IPO for the HIV-focused ViiV as it sharpens the budget axe
GlaxoSmithKline weighs an IPO for the HIV-focused ViiV as it sharpens the budget axe
Submitted by
admin
on October 22, 2014 - 8:32am
Source:
Fierce Biotech
News Tags:
GSK
ViiV Healthcare
IPOs
HIV
Pfizer
Headline:
GlaxoSmithKline weighs an IPO for the HIV-focused ViiV as it sharpens the budget axe
Do Not Allow Advertisers to Use My Personal information
